Clinical case of surgical treatment of metastatic germ cell tumor of the testicle with simultaneous prosthesis of the inferior vena cava and aorta

Cover Page

Cite item

Full Text

Abstract

Germ cell tumors are malignant tumors that develop from germinal cells. Over 90 % of all germ cell tumors in men are represented by germ cell seminomas. The incidence of choriocarcinoma does not increase with age but reaches its peak among people aged 25 to 34 years. A clinical case of surgical treatment of metastatic testicular choriocarcinoma with simultaneous nephrectomy, retroperitoneal lymph node dissection, prosthesis of the inferior vena cava and the infrarenal aorta is presented. The most serious complication in this group of patients is prosthetic infection. The implemented stage-by-stage multidisciplinary treatment approach allowed to achieve a good oncological and functional result.

About the authors

Yuliya A. Churina

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Author for correspondence.
Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0000-0001-9642-8260
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

G. A. Ivanchenko

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0009-0008-6673-1603
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

V. O. Potanin

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0009-0004-4375-8847
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

A. A. Derinov

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0000-0001-9449-5945
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

A. N. Dzyundzya

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0000-0003-1133-8106
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

B. M. Tlisov

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0000-0003-4094-8771
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

A. R. Nigamatullina

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0009-0001-7725-8339
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

V. V. Shchegelskiy

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0000-0002-5133-011X
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

E. A. Bezrukov

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0000-0002-2746-5962
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

R. N. Komarov

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0000-0002-3904-6415
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

P. V. Tsarkov

I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)

Email: churina_yu_a@staff.sechenov.ru
ORCID iD: 0000-0002-7134-6821
Russian Federation, Build. 2, 8 Trubetskaya St., Moscow 119048

References

  1. Rumyantsev A.A., Gladkov O.A., Matveev V.B. et al. Practical recommendations for the treatment of germ cell tumors in men. Zlokachestvennye opukholi = Malignant Tumors 2022;12(3s2–1): 627–58. (In Russ.). doi: 10.18027/2224-5057-2022-12-3s2-627-658
  2. Coleman M.P., Estève J., Damiecki P. et al. Trends in cancer incidence and mortality. IARC Scientific Publications 1993;(121):1–806. doi: 10.3109/9780415874984-2
  3. Winter C., Pfister D., Busch J. et al. Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group. Eur Urol 2012;61(2):403–9. doi: 10.1016/j.eururo.2011.10.045
  4. Lavery H.J., Bahnson R.R., Sharp D.S., Pohar K.S. Management of the residual post-chemotherapy retroperitoneal mass in germ cell tumors. Ther Adv Urol 2009;1:199–207. doi: 10.1177/1756287209350315
  5. Travis L.B., Feldman D.R., Fung C. et al. Adolescent and young adult germ cell tumors: epidemiology, genomics, treatment, and survivorship. JCO 2024;42:696–706. doi: 10.1200/JCO.23.01099
  6. Evmorfopoulos K., Chasiotis G., Barbatis A. et al. Complete vascular replacement of the infrarenal inferior vena cava and abdominal aorta during post-chemotherapy retroperitoneal lymph node dissection for a non-seminomatous germ cell tumor. Cur Oncol 2023;30(6):5448–55. doi: 10.3390/curroncol30060412
  7. Kinebuchi Y., Ogawa T., Kato H. et al. Testicular cancer with tumor thrombus extending to the inferior vena cava successfully removed using veno-venous bypass: a case report. Int J Urol 2007;14(5):458–60. doi: 10.1111/j.1442-2042.2007.01757.x
  8. Heidenreich A., Thüer D., Polyakov S. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. Eur Urol 2008;53(2):260–74. doi: 10.1016/j.eururo.2007.10.033
  9. Mosharafa A.A., Foster R.S., Koch M.O. et al. Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 2004;171(5):1839–41. doi: 10.1097/01.ju.0000120141.89737.90
  10. Johnson S.C., Smith Z.L., Nottingham C. et al. Clinical and radiographic predictors of great vessel resection or reconstruction during retroperitoneal lymph node dissection for testicular cancer. Urology 2019;123:186–90. doi: 10.1016/j.urology.2018.08.028
  11. Caldarelli G., Minervini A., Guerra M. et al. Prosthetic replacement of the inferior vena cava and the iliofemoral vein for urologically related malignancies. BJU Int 2002;90(4):368–74. doi: 10.1046/j.1464-410X.2002.02919.x
  12. Heidenreich A., Haidl F., Paffenholz P. et al. Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours. Ann Oncol 2017;28(2):362–7. doi: 10.1093/annonc/mdw605
  13. Perera G.B., Fujitani R.M., Kubaska S.M. Aortic graft infection: update on management and treatment options. Vasc Endovascular Surg 2006;40(1):1–10. doi: 10.1177/153857440604000101
  14. Bunt T.J. Vascular graft infections: an update. Cardiovasc Surg 2001;9(3):225–33. doi: 10.1016/s0967-2109(00)00104-6
  15. Vogel T.R., Symons R., Flum D.R. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008;47(2):264–9. doi: 10.1016/j.jvs.2007.10.030
  16. Post I.C.J.H., Vos C.G. Systematic review and meta-analysis on the management of open abdominal aortic graft infections. Eur J Vasc Endovasc Surg 2019;58(2):258–81. doi: 10.1016/j.ejvs.2019.03.013
  17. Wilson S.E. New alternatives in management of the infected vascular prosthesis. Surg Infect 2001;2(2):171–7. doi: 10.1089/109629601750469492
  18. Valentine R.J. Diagnosis and management of aortic graft infection. Semin Vasc Surg 2001;14(4):292–301. doi: 10.1053/svas.2001.27874
  19. Hasse B., Husmann L., Zinkernagel A. et al. Vascular graft infections. Swiss Med Wkly 2013;143:w13754. doi: 10.4414/smw.2013.13754

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2026 Churina Y.A., Ivanchenko G.A., Potanin V.O., Derinov A.A., Dzyundzya A.N., Tlisov B.M., Nigamatullina A.R., Shchegelskiy V.V., Bezrukov E.A., Komarov R.N., Tsarkov P.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36986 от  21.07.2009.